The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2021

Filed:

Sep. 10, 2018
Applicant:

Allergan, Inc., Irvine, CA (US);

Inventors:

Jeffrey L. Edelman, Irvine, CA (US);

Patrick M. Hughes, Aliso Viejo, CA (US);

Thomas C. Malone, Irvine, CA (US);

Gerald W. DeVries, San Clemente, CA (US);

Joan-En Chang-Lin, Tustin, CA (US);

Jane-Guo Shiah, Irvine, CA (US);

Thierry Nivaggioli, Atherton, CA (US);

Lon T. Spada, Walnut, CA (US);

Wendy M. Blanda, Tustin, CA (US);

Assignee:

ALLERGAN, INC., Irvine, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61F 9/00 (2006.01); A61K 31/454 (2006.01); A61K 47/34 (2017.01); A61K 31/5377 (2006.01); A61K 9/20 (2006.01); A61K 31/404 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61F 9/0017 (2013.01); A61K 9/204 (2013.01); A61K 31/404 (2013.01); A61K 31/454 (2013.01); A61K 31/5377 (2013.01); A61K 47/34 (2013.01);
Abstract

Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.


Find Patent Forward Citations

Loading…